301301 川宁生物
已收盘 09-30 15:00:00
资讯
新帖
简况
股市必读:川宁生物(301301)9月22日董秘有最新回复
证券之星 · 09-22
股市必读:川宁生物(301301)9月22日董秘有最新回复
川宁生物:公司目前的维生素类产品有肌醇
证券之星 · 09-22
川宁生物:公司目前的维生素类产品有肌醇
川宁生物:玉米加工残渣主要是玉米芯和糖渣
证券之星 · 09-22
川宁生物:玉米加工残渣主要是玉米芯和糖渣
股市必读:川宁生物(301301)9月17日董秘有最新回复
证券之星 · 09-17
股市必读:川宁生物(301301)9月17日董秘有最新回复
川宁生物:与上海金珵科技建立战略合作关系
证券之星 · 09-17
川宁生物:与上海金珵科技建立战略合作关系
股市必读:川宁生物(301301)9月15日董秘有最新回复
证券之星 · 09-15
股市必读:川宁生物(301301)9月15日董秘有最新回复
川宁生物:中期票据获准注册 注册金额10亿元
格隆汇 · 09-12
川宁生物:中期票据获准注册 注册金额10亿元
川宁生物(301301.SZ)获准注册10亿元中期票据
智通财经 · 09-12
川宁生物(301301.SZ)获准注册10亿元中期票据
川宁生物股东大会通过公司章程修订及内部制度完善议案
中金财经 · 09-10
川宁生物股东大会通过公司章程修订及内部制度完善议案
川宁生物收盘下跌2.91%,滚动市盈率25.31倍,总市值275.64亿元
金融界 · 08-26
川宁生物收盘下跌2.91%,滚动市盈率25.31倍,总市值275.64亿元
图解川宁生物中报:第二季度单季净利润同比下降59.72%
证券之星 · 08-25
图解川宁生物中报:第二季度单季净利润同比下降59.72%
川宁生物:公司目前三大抗生素产品产线均为满产状态
证券之星 · 08-04
川宁生物:公司目前三大抗生素产品产线均为满产状态
川宁生物:麦角硫因未达满产但满足市场需求
证券之星 · 08-04
川宁生物:麦角硫因未达满产但满足市场需求
土地流转概念盘中跳水,川宁生物平盘
市场透视 · 07-31
土地流转概念盘中跳水,川宁生物平盘
川宁生物:公司的熊去氧胆酸已于2024年7月收到《化学原料药上市申请批准通知书》,已经上市销售
证券之星 · 06-05
川宁生物:公司的熊去氧胆酸已于2024年7月收到《化学原料药上市申请批准通知书》,已经上市销售
川宁生物:公司仅生产麦角硫因原料胶囊产品由科伦永年进行生产
证券之星 · 06-05
川宁生物:公司仅生产麦角硫因原料胶囊产品由科伦永年进行生产
川宁生物:公司合成生物学生产基地目前已经在生产麦角硫因原料
证券之星 · 06-05
川宁生物:公司合成生物学生产基地目前已经在生产麦角硫因原料
川宁生物:本次权益分派股权登记日为
证券之星 · 06-05
川宁生物:本次权益分派股权登记日为
川宁生物:公司第一季度营收和利润同比有所下降的主要原因是产品价格下降和研发费用增长
证券之星 · 05-22
川宁生物:公司第一季度营收和利润同比有所下降的主要原因是产品价格下降和研发费用增长
【5月16日两融净买入前十:招商银行(1.70亿元)、通化金马(1.67亿元)】沪深两市数据显示,5月16日,融资净买入前十的股票分别为:招商银行(1.70亿元)、通化金马(1.67亿元)、中国平安(1.37亿元)、贵州茅台(1.05亿元)、川宁生物(1.01亿元)、比亚迪(9853.49万元)、金达威(9791.52万元)、赤峰黄金(8209.69万元)、东土科技(8035.20万元)、精锻科技(7870.95万元)。
金融界 · 05-19
【5月16日两融净买入前十:招商银行(1.70亿元)、通化金马(1.67亿元)】沪深两市数据显示,5月16日,融资净买入前十的股票分别为:招商银行(1.70亿元)、通化金马(1.67亿元)、中国平安(1.37亿元)、贵州茅台(1.05亿元)、川宁生物(1.01亿元)、比亚迪(9853.49万元)、金达威(9791.52万元)、赤峰黄金(8209.69万元)、东土科技(8035.20万元)、精锻科技(7870.95万元)。
加载更多
公司概况
公司名称:
伊犁川宁生物技术股份有限公司
所属行业:
医药制造业
上市日期:
2022-12-27
主营业务:
伊犁川宁生物技术股份有限公司的主营业务是生物发酵技术的研发和产业化。公司的主要产品是硫氰酸红霉素、6-APA、青霉素G钾盐、7-ACA、7-ADCA、D-7ACA。
发行价格:
5.00
{"stockData":{"symbol":"301301","market":"SZ","secType":"STK","nameCN":"川宁生物","latestPrice":10.78,"timestamp":1759215834000,"preClose":10.83,"halted":0,"volume":9726966,"delay":0,"changeRate":-0.0046,"floatShares":618000000,"shares":2230000000,"eps":0.4883,"marketStatus":"已收盘","change":-0.05,"latestTime":"09-30 15:00:00","open":10.85,"high":10.88,"low":10.78,"amount":105000000,"amplitude":0.0092,"askPrice":10.78,"askSize":1653,"bidPrice":10.77,"bidSize":297,"shortable":0,"etf":0,"ttmEps":0.4883,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1759973400000},"marketStatusCode":5,"adr":0,"adjPreClose":10.83,"symbolType":"stock","openAndCloseTimeList":[[1759195800000,1759203000000],[1759208400000,1759215600000]],"highLimit":11.91,"lowLimit":9.75,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":2230085000,"isCdr":false,"pbRate":3.11,"roa":"--","peRate":22.076592,"roe":"5.59%","epsLYR":0.63,"committee":-0.631397,"marketValue":24040000000,"turnoverRate":0.0157,"status":1,"floatMarketCap":6660000000},"requestUrl":"/m/hq/s/301301","defaultTab":"news","newsList":[{"id":"2569273193","title":"股市必读:川宁生物(301301)9月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2569273193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569273193?lang=zh_cn&edition=full","pubTime":"2025-09-23 00:59","pubTimestamp":1758560354,"startTime":"0","endTime":"0","summary":"截至2025年9月22日收盘,川宁生物报收于11.3元,下跌0.79%,换手率1.85%,成交量11.41万手,成交额1.3亿元。董秘最新回复投资者: 请问公司现阶段生物制剂生产的主要原料是什么?当日关注点来自交易信息汇总:9月22日主力资金净流出2511.53万元,显示主力短期内可能持谨慎态度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092300001058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301301"],"gpt_icon":0},{"id":"2569175204","title":"川宁生物:公司目前的维生素类产品有肌醇","url":"https://stock-news.laohu8.com/highlight/detail?id=2569175204","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569175204?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:03","pubTimestamp":1758528199,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物(301301)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘你好,请问公司有哪些维生素类产品?川宁生物回复:尊敬的投资者,您好,公司目前的维生素类产品有肌醇,后续还会有一些维生素类、氨基酸类等合成生物学产品推出,感谢你对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200018764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2569520410","title":"川宁生物:玉米加工残渣主要是玉米芯和糖渣","url":"https://stock-news.laohu8.com/highlight/detail?id=2569520410","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569520410?lang=zh_cn&edition=full","pubTime":"2025-09-22 16:03","pubTimestamp":1758528198,"startTime":"0","endTime":"0","summary":"蛋白用于发酵或用于饲料,玉米皮用于饲料,玉米胚用于制油;3.淀粉加工过程中的残渣主要是玉米所携带的玉米芯,葡萄糖浆加工的过程中残渣主要是糖渣。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200018762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","MZCmain","301301","XCmain","ZCmain"],"gpt_icon":0},{"id":"2568199204","title":"股市必读:川宁生物(301301)9月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2568199204","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568199204?lang=zh_cn&edition=full","pubTime":"2025-09-18 03:03","pubTimestamp":1758135794,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘,川宁生物报收于11.44元,上涨0.26%,换手率1.9%,成交量11.71万手,成交额1.34亿元。董秘最新回复投资者: 川宁生物有Ai制药技术吗?董秘: 尊敬的投资者,您好,公司与上海金珵科技建立战略合作关系,具体详见2024年2月23日披露的《伊犁川宁生物技术股份有限公司关于签署战略合作协议的公告》。当日关注点来自交易信息汇总:9月17日主力资金净流出988.22万元,散户资金净流入1187.01万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800001386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2568466252","title":"川宁生物:与上海金珵科技建立战略合作关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2568466252","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568466252?lang=zh_cn&edition=full","pubTime":"2025-09-17 16:30","pubTimestamp":1758097848,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物(301301)09月17日在投资者关系平台上答复投资者关心的问题。投资者提问:川宁生物有Ai制药技术吗?川宁生物回复:尊敬的投资者,您好,公司与上海金珵科技建立战略合作关系,具体详见2024年2月23日披露的《伊犁川宁生物技术股份有限公司关于签署战略合作协议的公告》。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700028187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159830","301301","BK0239"],"gpt_icon":0},{"id":"2567814992","title":"股市必读:川宁生物(301301)9月15日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2567814992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567814992?lang=zh_cn&edition=full","pubTime":"2025-09-16 01:36","pubTimestamp":1757957775,"startTime":"0","endTime":"0","summary":"截至2025年9月15日收盘,川宁生物报收于11.39元,下跌1.04%,换手率2.07%,成交量12.81万手,成交额1.46亿元。董秘: 尊敬的投资者,您好,公司今年合成生物学还在产能爬坡阶段,但上半年已形成收入2232万元,感谢您对公司的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600001385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2566942609","title":"川宁生物:中期票据获准注册 注册金额10亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566942609","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566942609?lang=zh_cn&edition=full","pubTime":"2025-09-12 11:52","pubTimestamp":1757649125,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0028","BK0183","BK0239","LU0572939691.SGD","601166","LU1048596156.SGD","LU1328615791.USD","LU1580142542.USD","LU0264606111.USD","301301","BK0278","LU1781817850.SGD","LU0821914370.USD","BK0012","BK0188","LU0572940350.SGD","BK0187","BK0015"],"gpt_icon":0},{"id":"2566429859","title":"川宁生物(301301.SZ)获准注册10亿元中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2566429859","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566429859?lang=zh_cn&edition=full","pubTime":"2025-09-12 11:51","pubTimestamp":1757649074,"startTime":"0","endTime":"0","summary":"智通财经APP讯,川宁生物(301301.SZ)公告,公司收到交易商协会出具的《接受注册通知书》,交易商协会同意接受公司中期票据的注册,注册金额为10亿元,注册额度自本通知书落款之日起2年内有效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1344483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301301"],"gpt_icon":0},{"id":"2566467079","title":"川宁生物股东大会通过公司章程修订及内部制度完善议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2566467079","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566467079?lang=zh_cn&edition=full","pubTime":"2025-09-10 18:49","pubTimestamp":1757501343,"startTime":"0","endTime":"0","summary":"中访网数据 伊犁川宁生物技术股份有限公司于2025年9月10日成功召开了2025年第二次临时股东大会。本次会议审议并通过了《关于修订<公司章程>的议案》及《关于修订和制定公司部分内部制度的议案》等一系列重要议案。其中,《公司章程》修订议案获得了99.8051%的高票通过,体现了股东对公司治理结构优化的广泛支持。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20250910/31631517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","301301"],"gpt_icon":0},{"id":"2562782199","title":"川宁生物收盘下跌2.91%,滚动市盈率25.31倍,总市值275.64亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562782199","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562782199?lang=zh_cn&edition=full","pubTime":"2025-08-26 18:10","pubTimestamp":1756203036,"startTime":"0","endTime":"0","summary":"8月26日,川宁生物今日收盘12.36元,下跌2.91%,滚动市盈率PE达到25.31倍,总市值275.64亿元。从行业市盈率排名来看,公司所处的生物制品行业市盈率平均74.75倍,行业中值45.52倍,川宁生物排名第33位。股东方面,截至2025年6月30日,川宁生物股东户数54250户,较上次增加3161户,户均持股市值35.28万元,户均持股数量2.76万股。最新一期业绩显示,2025年半年报,公司实现营业收入23.49亿元,同比-26.50%;净利润4.55亿元,同比-40.64%,销售毛利率35.87%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26181052705695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2562221269","title":"图解川宁生物中报:第二季度单季净利润同比下降59.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562221269","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562221269?lang=zh_cn&edition=full","pubTime":"2025-08-26 02:12","pubTimestamp":1756145575,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物2025年中报显示,公司主营收入23.49亿元,同比下降26.5%;归母净利润4.55亿元,同比下降40.64%;扣非净利润4.56亿元,同比下降40.38%;其中2025年第二季度,公司单季度主营收入10.52亿元,同比下降37.11%;单季度归母净利润1.67亿元,同比下降59.72%;单季度扣非净利润1.73亿元,同比下降58.09%;负债率23.35%,投资收益-70.28万元,财务费用1583.83万元,毛利率35.87%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600003686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301"],"gpt_icon":0},{"id":"2556809885","title":"川宁生物:公司目前三大抗生素产品产线均为满产状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2556809885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556809885?lang=zh_cn&edition=full","pubTime":"2025-08-04 15:57","pubTimestamp":1754294253,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物(301301)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问:公司各产线满产吗?有新线新品投产计划吗?川宁生物回复:尊敬的投资者,您好,公司目前三大抗生素产品产线均为满产状态。暂未有新产线建设计划。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080400019416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301301"],"gpt_icon":0},{"id":"2556098806","title":"川宁生物:麦角硫因未达满产但满足市场需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2556098806","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556098806?lang=zh_cn&edition=full","pubTime":"2025-08-04 15:54","pubTimestamp":1754294054,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物(301301)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司的麦角硫因产品是否满产满销?川宁生物回复:尊敬的投资者,您好,麦角硫因产品在合成生物学柔性生产线生产,未达到满产状态,但麦角硫因目前能够满足现在市场所需。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080400018777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2555074683","title":"土地流转概念盘中跳水,川宁生物平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2555074683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555074683?lang=zh_cn&edition=full","pubTime":"2025-07-31 10:25","pubTimestamp":1753928750,"startTime":"0","endTime":"0","summary":"07月31日,土地流转概念盘中跳水,截至10点25分,土地流转概念整体指数下跌1.01%,报1381.040点。从个股上来看,该概念的成分股中,川宁生物平盘,ST朗源跌幅居前。从资金上来看,截止发稿,土地流转概念主力净流入为-2.10亿,其中中华企业受到资金热捧,主力净流入1506.93万;拉长时间线来看,该板块近20日主力资金净流入-40.77亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073110255094c516b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073110255094c516b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0184","BK0012","BK0102","600675","BK0239","BK0028","BK0099","BK0053","301301","BK0273"],"gpt_icon":0},{"id":"2541040163","title":"川宁生物:公司的熊去氧胆酸已于2024年7月收到《化学原料药上市申请批准通知书》,已经上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2541040163","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541040163?lang=zh_cn&edition=full","pubTime":"2025-06-05 17:01","pubTimestamp":1749114070,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物(301301)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,目前贵司的熊去氧胆酸是否有上市销售,昨天中山某国内熊去氧胆酸生产龙头企业发生火灾,未来市场的熊去氧胆酸供应可能面临较大缺口,贵公司是否有产能来满足市场需求?川宁生物回复:尊敬的投资者,您好,公司的熊去氧胆酸已于2024年7月收到《化学原料药上市申请批准通知书》,已经上市销售,公司会根据市场情况随行就市,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060500023857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301301"],"gpt_icon":0},{"id":"2541040198","title":"川宁生物:公司仅生产麦角硫因原料胶囊产品由科伦永年进行生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2541040198","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541040198?lang=zh_cn&edition=full","pubTime":"2025-06-05 17:01","pubTimestamp":1749114069,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物(301301)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司刘董事长亲自宣传的麦角硫因胶囊是由川宁生物生产的吗?公司还有类似的药物上市吗?谢谢回复!川宁生物回复:尊敬的投资者,您好,公司仅生产麦角硫因原料,胶囊产品是由科伦永年进行生产,在合成生物学领域,公司聚焦保健品原料、生物农药、高附加值天然产物、高端化妆品原料等板块,目前已有红没药醇、5-羟基色氨酸、角鲨烷、麦角硫因、肌醇等产品落地。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060500023855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301","BK0239"],"gpt_icon":0},{"id":"2541401660","title":"川宁生物:公司合成生物学生产基地目前已经在生产麦角硫因原料","url":"https://stock-news.laohu8.com/highlight/detail?id=2541401660","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541401660?lang=zh_cn&edition=full","pubTime":"2025-06-05 17:01","pubTimestamp":1749114068,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物(301301)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问:请问贵公司生产麦角硫因吗!川宁生物回复:尊敬的投资者,您好,公司合成生物学生产基地目前已经在生产麦角硫因原料。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060500023853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301301"],"gpt_icon":0},{"id":"2541040523","title":"川宁生物:本次权益分派股权登记日为","url":"https://stock-news.laohu8.com/highlight/detail?id=2541040523","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541040523?lang=zh_cn&edition=full","pubTime":"2025-06-05 16:57","pubTimestamp":1749113826,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物(301301)06月05日在投资者关系平台上答复投资者关心的问题。投资者提问:请问董秘,股东大会都开了24年的分红股权登记日是哪天?谢谢川宁生物回复:尊敬的投资者,您好,本次权益分派股权登记日为:2025年6月9日,感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060500023736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301301"],"gpt_icon":0},{"id":"2537899720","title":"川宁生物:公司第一季度营收和利润同比有所下降的主要原因是产品价格下降和研发费用增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2537899720","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537899720?lang=zh_cn&edition=full","pubTime":"2025-05-22 16:00","pubTimestamp":1747900856,"startTime":"0","endTime":"0","summary":"证券之星消息,川宁生物(301301)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问:301301请问公司一季度营业收入和净利润大幅下降的原因是什么?经营现金流同样大幅下降的原因是什么?川宁生物回复:尊敬的投资者您好,公司第一季度营收和利润同比有所下降的主要原因是:1、公司产品6-APA的市场价格有所下降:2、公司整体的研发费用同比有所增长。公司经营现金流下降的主要原因是由于票据贴现减少。感谢您对公司的关注。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200021701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301301"],"gpt_icon":0},{"id":"2536469235","title":"【5月16日两融净买入前十:招商银行(1.70亿元)、通化金马(1.67亿元)】沪深两市数据显示,5月16日,融资净买入前十的股票分别为:招商银行(1.70亿元)、通化金马(1.67亿元)、中国平安(1.37亿元)、贵州茅台(1.05亿元)、川宁生物(1.01亿元)、比亚迪(9853.49万元)、金达威(9791.52万元)、赤峰黄金(8209.69万元)、东土科技(8035.20万元)、精锻科技(7870.95万元)。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536469235","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536469235?lang=zh_cn&edition=full","pubTime":"2025-05-19 09:07","pubTimestamp":1747616825,"startTime":"0","endTime":"0","summary":"沪深两市数据显示,5月16日,融资净买入前十的股票分别为:招商银行(1.70亿元)、通化金马(1.67亿元)、中国平安(1.37亿元)、贵州茅台(1.05亿元)、川宁生物(1.01亿元)、比亚迪(9853.49万元)、金达威(9791.52万元)、赤峰黄金(8209.69万元)、东土科技(8035.20万元)、精锻科技(7870.95万元)。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/19090750484481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2226246903.HKD","EVS.SI","002626","159982","PNGAY","300258","600519","BK0186","600036","82318","000766","301301","BYDDY","81211","601318","600988","LU0128522744.USD","LU0348816934.USD","002594","LU1439103000.SGD","LU1868838027.USD","83189","HPAD.SI","HYDD.SI","LU0197773160.USD","03968","LU0289739343.SGD","03189","LU","LU0359201885.HKD","PAImain","03145","LU0348735423.USD","LU0823038988.USD","LU2293587155.HKD","LU0197773673.USD","BK0196","03143","LU1770034418.SGD","300353","399300","BK0127","LU1235295612.USD","LU0417516738.SGD","LU0823039010.USD","LU1820825898.SGD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1759958162817,"stockEarnings":[{"period":"1week","weight":-0.0227},{"period":"1month","weight":-0.0895},{"period":"3month","weight":-0.1084},{"period":"6month","weight":-0.1716},{"period":"1year","weight":-0.1934},{"period":"ytd","weight":-0.0717}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0064},{"period":"3month","weight":0.1239},{"period":"6month","weight":0.1618},{"period":"1year","weight":0.1637},{"period":"ytd","weight":0.1584}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"伊犁川宁生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"54250人(较上一季度增加6.19%)","perCapita":"11387股","listingDate":"2022-12-27","address":"新疆维吾尔自治区伊犁哈萨克自治州霍尔果斯市霍尔果斯经济开发区伊宁园区拱宸路1号","registeredCapital":"223008万元","survey":" 伊犁川宁生物技术股份有限公司的主营业务是生物发酵技术的研发和产业化。公司的主要产品是硫氰酸红霉素、6-APA、青霉素G钾盐、7-ACA、7-ADCA、D-7ACA。","listedPrice":5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"川宁生物(301301)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供川宁生物(301301)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"川宁生物,301301,川宁生物股票,川宁生物股票老虎,川宁生物股票老虎国际,川宁生物行情,川宁生物股票行情,川宁生物股价,川宁生物股市,川宁生物股票价格,川宁生物股票交易,川宁生物股票购买,川宁生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"川宁生物(301301)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供川宁生物(301301)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}